Abstract
Several neoplasms including cutaneous T-cell lymphomas, malignant melanoma and Kaposi's sarcoma have been successfully treated with systemic or intralesional interferons (IFNs). Recently, intralesional alpha-IFN has also been employed in the treatment of basal cell carcinoma (BCC).
| Lingua originale | English |
|---|---|
| pagine (da-a) | 214-217 |
| Numero di pagine | 4 |
| Rivista | Dermatology |
| Volume | 190 |
| Stato di pubblicazione | Pubblicato - 1995 |
Keywords
- Adult
- Aged
- Carcinoma, Basal Cell
- Drug Administration Schedule
- Fatigue
- Female
- Fever
- Follow-Up Studies
- Headache
- Humans
- Injections, Intralesional
- Interferon-alpha
- Male
- Middle Aged
- Nausea
- Recombinant Proteins
- Remission Induction
- Skin Neoplasms